A POST-REMISSION MAINTENANCE TREATMENT WITH LOW-DOSE CHEMOTHERAPY + RETINOIDS ANDDIHYDROXYLATED VITAMIN D3 MAY IMPROVE THE SURVIVAL OF POOR-PROGNOSIS AML/MDS PATIENTSDario Ferrero, Boccadoro Mario, Filippo Marmont et al.|Haematologica|2014Cited by 0